The interaction of PD-1 and PD-L1 suppresses T cell receptor-mediated cytotoxicity and CD8+ T cell proliferation, which negatively regulate the adaptive antitumor immune response, avoid the killing effect on tumor cells, and evade immune surveillance (11, 16). The gene discussed is PDCD1; the disease is neoplasm.